Stay updated with the latest Other news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on Other topics.
New Delhi [India], August 22 (ANI): India drug regulator has alerted on the theft of multiple drug products of Novo Nordisk during transit. According to the notice issued by the Drugs Controller General of India (DCGI), Dr Rajeev Raghuvanshi, Mis Novo Nordisk has informed about a theft of its products, as mentioned below, during transit from its Bhiwandi Hub to milk route (Nagpur, Raipur, Cuttack, and Kolkata). The DCGI has also mentioned in the notice that the quality of the injectables is required to be stored at 2-8 degrees Celsius; if not handled properly, storage quality might be compromised. The products under consideration are rDNA origin injectables, which are required to be stored at 2-8 °C. The quality of the products may be compromised if the products are not handled in proper storage conditions, since the formulations are supposed to be maintained at 2 °C to 8 °C, failing which would impact the quality of the product and, in turn, impact the safety of the patients. The matter is currently under investigation by the Police, the DCGI said. These products are of Batch NO. 1 Insulin degludec/ Insulin Aspart (r-DNA origin) solution for injection RT6GY9G (RyzodegM FlexTouch 2, Insulin aspart (-DNA Origin), solution for injection Fiaspe Penifill) RR726A8 3. Insulin aspart (r-DNA Origin), solution for injection (Fiasp@ FlexTouch@) RP5P640 4. Semaglutide Injection 0.5mg (r-DNA Origin), solution for injection RP5S233 (Wegovye FlexTouch@) 5. Semaglutide Injection 0.25 mg (r-DNA Origin), solution for injection RP5S232 (WegovyR FlexTouche) 6. Semaglutide Injection 1 mg (-DNA Origin), solution for injection RP5S210 (WegovyR FlexTouchR) Doctors and Healthcare professionals should carefully prescribe and educate patients to report any Adverse Drug Reactions (ADRs). Patients and consumers are to be careful and procure the above products from authorised sources only and with a proper invoice, the DCGI stated. The notice has been issued to the regulatory authorities of all state/UT Drugs Controllers and Zonal/Sub-Zonal offices of the Central Drugs Standard Control Organisation (CDSCO). (ANI) Disclaimer: This news article is a direct feed from ANI and has not been edited by the News Nation team. The news agency is solely responsible for its content.
GURGAON: The investigation into the murder of a 25-year-old former international tennis player, allegedly by her father, has revealed a sudden deterioration in their relationship. The apparent reason was a disagreement over the academy she ran near their house, but the roots clearly run deeper. The father, who claims to have spent Rs 2 crore on his daughter's tennis career, told interrogators he was troubled by questions about her "character" that some of his associates had raised.Deepak Yadav, who shot Radhika at their house Thursday morning, had allegedly been insisting for two weeks on her ...Read More >
A ₹1,000 crore market is set to grow 5x to ₹5,000 crore by 2030 as prices drop 40-50% post patent expiry. Three early movers are taking sharply different routes -- low-cost, premium, and partnerships in a high-stakes land grab. The Indian market for Glucagon-Like Peptide-1 (GLP-1) therapies is currently at an inflection point and is poised for strong expansion. The current market size for anti-obesity and diabetes GLP-1 drugs in India, as of 2025, is estimated to be between ₹1,000-1,200 cr ...Read More >
Mumbai: Less than a month after Ozempic maker Novo Nordisk announced it is cutting its global workforce as part of a restructuring plan, the layoffs have hit Indian employees in Bengaluru. Junior- to mid-level employees across functions such as sales and marketing, as well as those in the company's global business services (GBS) hub, which works with its global teams, have been impacted, according to at least three people aware of the development. "At least 100-150 will be retrenched from the commercial unit, which largely includes sales and marketing roles. They are expected to be in junior ...Read More >
Bangalore : Emcure Pharmaceuticals Ltd., (BSE: 544210, NSE: EMCURE) has announced the price revision of its weight management drug Poviztra® (semaglutide injection) across India. The reduced price would be starting at Rs. 3,999/- per month (4 weekly doses). The innovator Semaglutide is available in a once-weekly pen device in five strengths of 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and a maintenance dose of 2.4 mg. It comes in a state-of-the-art pen device that provides the convenience of simple administration and precise dosing. As the first Indian company to exclusively distribute and commercialis ...Read More >
HYDERABAD, India, April 3 (Reuters) - Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for weight-loss drugs in India. New Delhi wellness clinic Klarity Skin Clinic touts a "Mounjaro bride" package, while other clinics have woven weight-loss injections into "pre-wedding" transformation packages typically focused on skin treatments and hairstyle makeovers. In a social media video, Klarity offers "guided nutrition, Mounjaro and smart workouts" to prepare brides to walk down the aisle. The clinic did not respond to a reques ...Read More >
New Delhi [India], September 30 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has approved Danish drugmaker Novo Nordisk's once-a-week injection for patients suffering from Type 2 diabetes. Also Read | Durga Puja 2025: PM Narendra Modi Participates in Durga Puja Celebrations in Delhi's CR Park on Occasion of Maha Ashtami, Prays for Everyone's Happiness and Wellbeing (See Pics). In a statement provided to ANI, Novo Nordisk has stated that Ozempic is intended for individuals with Type 2 diabetes and will be available only upon a doctor's prescription. "Ozempic is meant for pe ...Read More >
New Delhi, July 19 (PTI) The Regional Medical Research Centre in Bhubaneswar, under the Indian Council of Medical Research (ICMR), has developed an advanced malaria vaccine that can prevent plasmodium falciparum infection in individuals and minimise community transmission. The ICMR Delhi has invited Expressions of Interest (EoI) from eligible organisations, companies and manufacturers enthusiastic about the Transfer of Technology for commercial production of "a recombinant chimeric multi-stage malaria vaccine (AdFalciVax) against plasmodium falciparum". The pre-clinical validation of this te ...Read More >
MUMBAI, Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to bring its experimental oral weight-loss drug orforglipron to India as it sees market potential in the world's most populous nation, a senior executive said on Thursday. "I do think there is promise for products like that (orforpligron) in India, if it does get approved," Winselow Tucker, Lilly India's president said at an event in Mumbai. Tucker, however, did not indicate when Lilly plans to launch the drug. The drugmaker ha ...Read More >
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular weight-loss drug Wegovy over fears of falling behind rival Eli Lilly in the potentially huge market, two sources familiar with the plans told Reuters. Officials at the Danish drugmaker have said Wegovy might be introduced in India in 2026 once regulatory approvals are in hand and there is sufficient supply. More recently, Novo's India team proposed moving the launch to next year, around the same time Lilly is expected to introduce its weight-loss drug Mounjaro. In a clo ...Read More >
Mumbai: Emcure Pharmaceuticals has reduced the price of its weight management drug Poviztra (semaglutide injection) across India by an average of 47% across dosages in a bid to widen patient access. The starting dose price is cut by 55% to Rs 3,999 per month (four weekly doses). The innovator semaglutide is available in a once-weekly pen device in five strengths of 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and a maintenance dose of 2.4 mg with the highest dose priced at Rs 8,999 for a month's supply. Emcure has a marketing tie-up with the Danish innovator Novo Nordisk to distribute and commercialise a ...Read More >
Jaipur: Senior Congress leader and former chief minister Ashok Gehlot criticised the Bhajan Lal Sharma-led BJP govt in Rajasthan, accusing it of surrendering to the sand mafia and failing to uphold law and order in the state. Speaking on the birth anniversary of senior Congress leader Late Girija Vyas at PCC Tuesday, Gehlot said, "The sand mafia has completely taken over. Sand prices are skyrocketing, and the common man can't even afford to build a home. During our tenure, we faced challenges too, but we tried to control them. Today, it's a free-for-all."He alleged that a deep-rooted nexus now ...Read More >
Indian brides are turning to low-cost weight-loss injections ahead of their weddings. Freepik ShowQuick Read Summary is AI-generated, newsroom-reviewed * Soon-to-be Indian brides and grooms increasingly seek weight-loss drugs before weddings * Mounjaro is preferred over Wegovy and prescribed only for medically eligible patients * Regulators warn against misuse amid cheaper local weight-loss drug versions flooding market Did our AI summary help? Let us know. Switch To Beeps Mode Soon-to- ...Read More >
HYDERABAD, India, April 3 (Reuters) - Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for weight-loss drugs in India. New Delhi wellness clinic Klarity Skin Clinic touts a "Mounjaro bride" package, while other clinics have woven weight-loss injections into "pre-wedding" transformation packages typically focused on skin treatments and hairstyle makeovers. In a social media video, Klarity offers "guided nutrition, Mounjaro and smart workouts" to prepare brides to walk down the aisle. The clinic did not respond to a requ ...Read More >
HYDERABAD: Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for weight-loss drugs in India. New Delhi wellness clinic Klarity Skin Clinic touts a "Mounjaro bride" package, while other clinics have woven weight-loss injections into "pre-wedding" transformation packages typically focused on skin treatments and hairstyle makeovers. Also Read: Weight-loss drug boom: Will cheaper Ozempic generics shake up India's fitness and nutrition industry? In a social media video, Klarity offers "guided nutrition, Mounjaro and smart work ...Read More >
NEW DELHI: Come Saturday and people can whistle into Srinagar on a train as Northern Railway has notifed regular Vande Bharat Express services between Katra and the city. PM Narendra Modi will flag off the first passenger train to the Kashmir Valley on Friday from Katra.The service will be operational for six days a week with no train on Wednesday, railways said. More trains would be deployed depending on demand at a later stage, officials added. From Saturday, a pair of Vande Bharat trains will operate on the Srinagar-Katra-Srinagar route with an intermediate halt at Banihal. Journey time wil ...Read More >
New Delhi, Sep 30 (PTI) India's drug regulator Central Drugs Standard Control Organisation (CDSCO) has approved Ozempic (semaglutide injection) manufactured by Danish pharma company Novo Nordisk for use in adults with type-2 diabetes. According to sources, Ozempic, the once-a-week injection, will be available only on a doctor's prescription. "Semaglutide Injection (Ozempic@) is indicated for the treatment of adults with Insufficiently Controlled Type 2 Diabetes Mellitus as an adjunct to Diet and Exercise," the approval by CDSCO said on September 26. The US Food and Drug Administration had a ...Read More >
New Delhi, Apr 2 (PTI) Emcure Pharmaceuticals on Thursday announced a reduction in the price of its weight management drug, Poviztra, a semaglutide injection, by up to 55 per cent to expand patient access. The starting dose of Poviztra (0.25 mg) will now be available at Rs 3,999 per month (inclusive of taxes), a reduction of 55 per cent from the previous price of Rs 8,790, with the price reduction effective from April 3, 2026. Across all doses, the price of Poviztra has been reduced by an average of 47 per cent. The drug is offered in five strengths: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and a ma ...Read More >
Chennai/New Delhi, June 27 (UNI) The CBI conducted nation-wide raids at 42 locations in five states and arrested nine people in connection with Mule Bank Accounts being used in Cyber frauds. In continuation of its on-going efforts to combat Cyber Crime and Digital Arrest Scams, the CBI acting on specific information and after verification launched coordinated searches at 42 locations across five States--Rajasthan, Delhi, Haryana, Uttarakhand and Uttar Pradesh--as part of the Operation Chakra-V to deal with the menace of mule bank accounts. The mule bank accounts were being opened by organ ...Read More >
India has officially approved the use of Ozempic (semaglutide), a once-a-week injection designed for adults with type 2 diabetes. Approved by the Central Drugs Standard Control Organisation (CDSCO), this drug has made headlines worldwide not just for diabetes management but also for its weight loss effects. As India faces rising rates of diabetes, Ozempic's arrival is more than just a medical update, it could influence lifestyle choices for millions.Here's all we need to know about what this new development means, its potential benefits, risks, and lifestyle implications.What exactly is Ozempi ...Read More >
Amritsar, July 18 (SocialNews.XYZ) Leader of Opposition in Punjab and Congress lawmaker Partap Singh Bajwa, on Friday demanded that Chief Minister Bhagwant Mann immediately convene an all-party meeting in Amritsar to discuss continuing threats to the Golden Temple through threatening emails. Speaking after paying obeisance at Sri Harmandir Sahib, where he was accompanied by Congress MP Gurjeet Singh Aujla, Sukhwinder Singh Danny Bandala and other Congress leaders, Bajwa said that he met with officials of the Shiromani Gurdwara Parbandhak Committee (SGPC). The SGPC officials told him that eve ...Read More >
(Reuters) -Eli Lilly will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, as it seeks to tap into skilled workforce to bolster its global manufacturing expansion. The collaborations aim to increase the availability of Lilly's key drugs, including those for obesity, diabetes, Alzheimer's, cancer and autoimmune conditions, the company said. "We are making significant investments to increase manufactur ...Read More >
New Delhi, Mar 31 (PTI) Novo Nordisk India on Tuesday announced price reductions for Ozempic and Wegovy in India, days after the launch of generic versions of semaglutide injections for patients living with type 2 diabetes and obesity. Indian pharma majors recently announced the launch of their generic versions following the molecule behind products like Ozempic and Wegovy, going off patent in India. Effective April 1, 2026, the price of the starting dose of Ozempic will be reduced by 36 per cent, while that of the starting dose of Wegovy will be reduced by 48 per cent in India. Ozempic (0. ...Read More >
FDA Approves Kirsty (insulin aspart-xjhz), an Interchangeable Biosimilar to NovoLog BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India: July 15, 2025 -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration (FDA) has approved Kirsty™ (Insulin Aspart-xjhz), 100 units/mL as the first and only interchangeable* biosimilar to NovoLog® (Insulin ...Read More >
CHENNAI: Governor R N Ravi, Chief Minister M K Stalin, AIADMK general secretary Edappadi K Palaniswami, and leaders of political parties paid tributes to freedom fighter Dheeran Chinnamalai on his death anniversary on Sunday. "The nation pays humble tribute to the great patriot, visionary leader and fearless commander Dheeran Chinnamalai. With unmatched courage and strategic brilliance, he led relentless campaigns against the oppressive British East India Company, boldly challenging colonial tyranny," the governor said in his message. The CM, accompanied by his Cabinet colleagues, paid flora ...Read More >
Bengaluru: Bangalore are you tired of trying viral trends and 'magic remedies' from social media to reduce weight? Today's youth want to be healthy, but a lack of correct information often leads them down the wrong path. Obesity is a complex medical condition that cannot be solved by a two-day diet or a viral challenge. What one needs is a scientific and reliable approach. The good news is that modern science now has a solution - called GLP1 RA (glucagon-like-peptide receptor agonist). This is a once-a-week injectable medicine called semaglutide that works on the root causes of obesity to help ...Read More >
HYDERABAD: Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for weight-loss drugs in India. New Delhi wellness clinic Klarity Skin Clinic touts a "Mounjaro bride" package, while other clinics have woven weight-loss injections into "pre-wedding" transformation packages typically focused on skin treatments and hairstyle makeovers. In a social media video, Klarity offers "guided nutrition, Mounjaro and smart workouts" to prepare brides to walk down the aisle. The clinic did not respond to a request for comment. Eight doctor ...Read More >
Hyderabad: Contrary to widespread and distressing reports circulating on social media and some unofficial sources earlier today, Jubilee Hills MLA Maganti Gopinath of the Bharat Rashtra Samithi (BRS) has not passed away. He remains critically ill but is showing signs of recovery after being rushed to AIG Hospital in Gachibowli on Thursday with heart-related issues. BRS MLC Dasoju Shravan provided a crucial update, stating, "Maganti Gopinath is recovering." Shravan clarified that Gopinath is responding to medical treatment. He attributed the MLA's serious health condition to immense stress fol ...Read More >
New Delhi [India], August 14 (ANI): The credit-to-deposit ratio in Indian banks has stayed below 80 per cent as credit offtake in the country continues to lag, according to a report by CareEdge Ratings. The report highlighted that while both credit offtake and deposit growth have increased sequentially, they remain significantly lower than the levels seen last year. Deposits continued to outpace credit offtake in the current fortnight, leading to a narrowing of the credit-deposit gap. It stated Credit to Deposit Ratio Remains Below 80 per cent as Credit Offtake Lags. The report data pointed ...Read More >
March 31 (Reuters) - Novo Nordisk has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and 48% in India, to fend off competition from cheaper generics made by local drugmakers. India's market for diabetes and weight-loss drugs is set for a shake-up after the Danish drugmaker's patent on semaglutide, the active component in Ozempic and Wegovy, expired on March 20. At least half a dozen Indian drugmakers, including Dr Reddy's, Zydus an ...Read More >
A groundbreaking study led by an Indian-origin researcher reveals that GLP-1 receptor agonists, originally developed for diabetes treatment, can also protect kidneys, regardless of diabetes status. The study, published in The Lancet Diabetes & Endocrinology, shows that these drugs, including semaglutide, liraglutide, and dulaglutide, reduce the risk of kidney failure by 16% and improve kidney function by 22%. Involving 85,373 participants, the research highlights the potential of GLP-1 receptor agonists in managing chronic kidney disease (CKD), offering hope for millions affected by the condit ...Read More >